| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514118000 | Phosphorus single bonded directly to nitrogen | 8 |
| 20100190753 | Methods and Compositions for Treating Amyloid-Related Diseases - Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-+related disease. | 07-29-2010 |
| 20110034421 | CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT - The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine. | 02-10-2011 |
| 20110224175 | FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION - Formulations of canfosfamide and their preparation. | 09-15-2011 |
| 20130072462 | Mitochondrial Compositions and Uses Thereof | 03-21-2013 |
| 20130217653 | FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION - This invention provides stable, lyophilized formulations of canfosfamide as well as the methods of preparation of those stable lyophilized formulations. | 08-22-2013 |
| 20140045798 | MITOCHONDRIAL COMPOSITIONS AND USES THEREOF - The present invention provides a compound of Formula Ia, wherein R | 02-13-2014 |
| 20140135294 | PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS - The present disclosure relates to pantothenate derivatives for the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders. | 05-15-2014 |
| 20160015727 | PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS - The present disclosure relates to pantothenate derivatives for the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders. | 01-21-2016 |
